UPDATE: Actavis trumps Valeant with $66B offer for Allergan

Allergan agrees to a $66 billion takeover bid from Actavis, thwarting a hostile takeover bid by Valeant Pharmaceuticals and William Ackman's Pershing Square Capital Management.

Actavis, Pershing Square Capital Management, Valeant Pharmaceuticals, Allergan Inc.

News Well, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uyrSf1